Evaluation of the Angiographic Grading Scale in Aneurysms Treated with the WEB Device in 80 Rabbits: Correlation with Histologic Evaluation

ABSTRACT BACKGROUND AND PURPOSE: The WEB Occlusion Score has been proposed to assess angiographic outcomes for intracranial aneurysms treated with the Woven EndoBridge (WEB) device. Using a large series of experimental aneurysms treated with the WEB, we had the following objectives: 1) to compare angiographic outcomes as measured by the WEB Occlusion Scale with histologic results, and 2) to assess interobserver and intraobserver agreement of the WEB Occlusion Scale

Intracranial Aneurysm Classifier Using Phenotypic Factors: An International Pooled Analysis

Intracranial aneurysms (IAs) are usually asymptomatic with a low risk of rupture, but consequences of aneurysmal subarachnoid hemorrhage (aSAH) are severe. Identifying IAs at risk of rupture has important clinical and socio-economic consequences. The goal of this study was to assess the effect of patient and IA characteristics on the likelihood of IA being diagnosed incidentally versus ruptured. Patients were recruited at 21 international centers. Seven phenotypic patient characteristics and three IA characteristics were recorded. The analyzed cohort included 7992 patients. Multivariate analysis demonstrated that: (1) IA location is the strongest factor associated with IA rupture status at diagnosis; (2) Risk factor awareness (hypertension, smoking) increases the likelihood of being diagnosed with unruptured IA; (3) Patients with ruptured IAs in high-risk locations tend to be older, and their IAs are smaller; (4) Smokers with ruptured IAs tend to be younger, and their IAs are larger; (5) Female patients with ruptured IAs tend to be older, and their IAs are smaller; (6) IA size and age at rupture correlate. The assessment of associations regarding patient and IA characteristics with IA rupture allows us to refine IA disease models and provide data to develop risk instruments for clinicians to support personalized decision-making

Formation and Persistence of Metabolites of Imazamethabenz-methyl in a Sandy Loam Soil

The fate of imazamethabenz-methy1 was studied in a sandy loam soil after application in spring to winter wheat (Triticum aestivum L.). Imazamethabenz-methyl and its metabolite 2 (2-(4, 5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-H-1-imidazol-2-yl)4-methylbenzoic acid, in mixture with the 5-methylbenzoic acid isomer) were further transformed into the metabolites 3 (2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-H-1-imidazol-2-yl)-1,4-benzenedicarboxylic acid, in mixture with the 1,5-benzenedicarboxylic acid isomer), and 4 (1,2,4-benzenetricarboxylic acid, in mixture with the 1,2,5-isomer). Meta-bolites 3 and 4 reached maximum concentration levels in the 0-13 cm layer corresponding to 14-17% and 9-14% of the imazamethabenz-methy1 dose, respectively. These maxima were reached be tween 105 and 177 days after application. Imazamethabenz-methyl metabolism was slower in plots treated with organic fertilizers than in untreated plots. After 196 days the concentrations of all metabolites in the 0-13 cm layer had declined to, at most, 0.01 mg kg(-1). There was no carry-over of residues that could be phytotoxic to the next crop